Metronics Introduces Brain-Stimulation Implants
By wchung | 17 Jun, 2026
Medtronic Inc. said Tuesday it began marketing two surgically implanted devices that are intended to help relieve symptoms for patients with neurodegenerative diseases.
The Minneapolis company said it is now marketing the Activa RC and Activa PC neurostimulators in Canada, and the first implantation of the new device has already taken place. The products are intended to reduce symptoms by stimulating the brain electronically.
Medtronic said the devices have new programming options, are smaller than its older models, and feature rechargeable batteries that can last up to nine years before a replacement is needed. The neurostimulators are used to treat conditions like Parkinson’s disease and tremors.
In afternoon trading, Medtronic shares added 65 cents to $43.09.
2/16/2010 1:30 PM NEW YORK (AP)
© 2026 by Asian Media Group Inc.
Recent Articles
- US Holds off Blacklisting DeepSeek, Over 100 Firms Deemed Security Risks
- Vietnam Maintains 2026 GDP Target Despite Trade Deficit, Inflation Pressure
- China Makes New Push to Take Yuan Global
- Iran Deal Includes $300 Billion Investment Fund, With Over Half Already Committed
- US Senate Narrowly Blocks New Bid to Rein in Trump War Powers
- BYD Ramps up Battery Production in Brazil
- Intel Begins Chip Production with New Fabrication Process
- 'Wingman' Drone Key Piece of EU's Defense Self-Reliance
- Keiko Fujimori Edges Ahead in Brutal Contested Vote Count
- Chip Queen He Tingbo Subverts Moore's Law to Overturn the Global Semiconductor Hierarchy